Valuation: Makers Laboratories Limited

Market Cap 113.29Cr 1.19Cr 1.07Cr 97.99L 89.2L 1.67Cr 1.7Cr 12Cr 4.66Cr 59Cr 4.48Cr 4.39Cr 187.4Cr P/E 2025
10.2x
P/E 2026 33.9x
Enterprise Value 107.64Cr 1.14Cr 1.01Cr 93.11L 84.75L 1.59Cr 1.62Cr 11Cr 4.43Cr 56Cr 4.26Cr 4.17Cr 178.05Cr EV / Sales 2025
0.67x
EV / Sales 2026 0.53x
Free-Float
32.46%
Yield 2025 *
-
Yield 2026 -

Last Transcript: Makers Laboratories Limited

1 day-3.98%
1 week-4.00%
Current month+3.53%
1 month+1.56%
3 months+24.72%
6 months+25.70%
Current year+62.51%
1 week 188
Extreme 188
239
1 month 174.75
Extreme 174.75
239
Current year 112.1
Extreme 112.1
239
1 year 109
Extreme 109
239
3 years 105
Extreme 105
239
5 years 94
Extreme 94
239
10 years 23.2
Extreme 23.2
344.8
Manager TitleAgeSince
Director of Finance/CFO 59 30/10/2017
Compliance Officer - 23/05/2024
Sales & Marketing 54 02/08/2017
Director TitleAgeSince
Director/Board Member 51 11/08/2011
Director/Board Member 52 29/01/2018
Chairman 77 28/03/2019
Change 5-day change 1-year change 3-year change Capi.($)
-3.98%-4.00%+39.69%+65.80% 1.25Cr
+2.83%+8.10%+63.42%+123.50% 1,13300Cr
+3.81%+5.40%+39.47%+74.91% 62TCr
+0.14%+0.60%+23.25%+95.03% 50TCr
+0.03%+5.72%+39.64%+64.06% 38TCr
-1.76%-0.09%+68.04%+43.41% 37TCr
+1.58%+5.07%+23.26%+51.98% 29TCr
+2.90%+5.53%+4.06%+24.45% 26TCr
+2.04%+4.97%+48.53%+60.42% 24TCr
+2.36%+2.38%+26.68%+102.04% 19TCr
Average +0.50%+2.89%+37.60%+70.56% 39.88TCr
Weighted average by Cap. +0.48%+3.73%+43.30%+82.74%

Financials

2025 2026
Net sales 120.75Cr 1.27Cr 1.14Cr 1.04Cr 95.08L 1.78Cr 1.81Cr 13Cr 4.96Cr 63Cr 4.78Cr 4.68Cr 199.74Cr 140.87Cr 1.49Cr 1.32Cr 1.22Cr 1.11Cr 2.08Cr 2.12Cr 15Cr 5.79Cr 74Cr 5.57Cr 5.46Cr 233.03Cr
Net income 7.49Cr 8L 7L 6L 6L 11.07L 11.26L 78.24L 30.8L 3.92Cr 29.64L 29.02L 12Cr 2.35Cr 2L 2L 2L 2L 3L 4L 24.56L 10L 1.23Cr 9L 9L 3.89Cr
Net Debt 4.82Cr 5L 5L 4L 4L 7L 7L 50.34L 19.82L 2.53Cr 19.07L 18.67L 7.97Cr -5.65Cr -6L -5L -5L -4L -8L -8L -59.01L -23.23L -2.96Cr -22.36L -21.89L -9.35Cr
Projected Income Statement - Annual - Makers Laboratories Limited
Logo Makers Laboratories Limited
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Employees
114
Date Price Change Volume
22/26/22 ₹192.00 -3.98% 452
21/26/21 ₹199.95 -2.70% 2,101
19/26/19 ₹205.50 -0.87% 341
16/26/16 ₹207.30 +1.17% 1,227
15/26/15 ₹204.90 +2.45% 1,118
  1. Stock Market
  2. Stocks
  3. MAKERSL Stock